Emily Turton

All publications

Journal articles

• Sanders T, Fryer K, Greco M, Mooney C, Deary V & Burton C (2025) Explanation for symptoms and biographical repair in a clinic for persistent physical symptoms. Health and Social Care Delivery Research. View this article in WRRO
• Neilson AR, Mooney C, Sutton L, White D, Dawson J, Rowlands G, Thomas RE, Woodward J, Deary V & Burton C (2025) Cost-effectiveness of an extended-role general practitioner clinic for persistent physical symptoms: results from the Multiple Symptoms Study 3 pragmatic randomized controlled trial. Health and Social Care Delivery Research. View this article in WRRO
• Burton C, Mooney C, Sutton L, White D, Dawson J, Neilson AR, Rowlands G, Thomas S, Horspool M, Fryer K , Greco M et al (2025) Effectiveness of a symptom-clinic intervention delivered by general practitioners with an extended role for people with multiple and persistent physical symptoms in England: the Multiple Symptoms Study 3 pragmatic, multicentre, parallel-group, individually randomised controlled trial. Health and Social Care Delivery Research. View this article in WRRO
• Fryer K, Sanders T, Greco M, Mooney C, Deary V & Burton C (2025) Recognition, explanation, action, learning: teaching and delivery of a consultation model for persistent physical symptoms. Health and Social Care Delivery Research. View this article in WRRO
• Burton C, Mooney C, Sutton L, White D, Dawson J, Neilson AR, Rowlands G, Thomas S, Horspool M, Fryer K , Greco M et al (2024) Effectiveness of a symptom-clinic intervention delivered by general practitioners with an extended role for people with multiple and persistent physical symptoms in England: the Multiple Symptoms Study 3 pragmatic, multicentre, parallel-group, individually randomised controlled trial. The Lancet, 403(10444), 2619-2629. View this article in WRRO
• Petrie J, Loban A, Turton E, Derebecka J, North S, Herbert E & Hind D (2024) “Reality is frequently inaccurate” A case study examining the whens and whys of post-live database changes in a UK clinical trials unit *Douglas Adams. Contemporary Clinical Trials, 142. View this article in WRRO
• Gould RL, McDermott CJ, Thompson BJ, Rawlinson CV, Bursnall M, Bradburn M, Kumar P, Turton EJ, White DA, Serfaty MA , Graham CD et al (2024) Acceptance and Commitment Therapy plus usual care for improving quality of life in people with motor neuron disease (COMMEND): a multicentre, parallel, randomised controlled trial in the UK. The Lancet. View this article in WRRO
• Keetharuth AD, Gould R, McDermott C, Thompson B, Rawlinson C, Bradburn M, Bursnall M, Kumar P, Turton E, Tappenden P , White D et al (2024) Cost-effectiveness of acceptance and commitment therapy for people living with motor neuron disease, and their health-related quality of life. European Journal of Neurology. View this article in WRRO
• Lindsay JO, Hind D, Swaby L, Berntsson H, Bradburn M, Bannur C U, Byrne J, Clarke C, Desoysa L, Din S , Emsley R et al (2024) Autologous stem cell transplantation with low-dose cyclophosphamide to improve mucosal healing in adults with refractory Crohn’s disease: the ASTIClite RCT. Efficacy and Mechanism Evaluation, 11(3). View this article in WRRO
• Jones G, Bailey L, Beeken RJ, Brady S, Cooper C, Copeland RJ, Crosland S, Dawson S, Faires M, Gilbody S , Haynes H et al (2024) Supporting physical activity through co-production in people with severe mental ill health (SPACES): protocol for a randomised controlled feasibility trial. Pilot and Feasibility Studies, 10(1). View this article in WRRO
• Lindsay JO, Hind D, Swaby E, Berntsson H, Bradburn M, Bannur U, Byrne J, Clarke C, Desoysa L, Dickins B , Din S et al (2024) Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn’s disease (ASTIClite): an open-label, multicentre, randomised controlled trial. The Lancet Gastroenterology and Hepatology. View this article in WRRO
• Tesfaye S, Sloan G, Petrie J, White D, Bradburn M, Young T, Rajbhandari S, Sharma S, Rayman G, Gouni R , Alam U et al (2022) Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT. Health Technology Assessment, 26(39). View this article in WRRO
• Tesfaye S, Sloan G, Petrie J, White D, Bradburn M, Julious S, Rajbhandari S, Sharma S, Rayman G, Gouni R , Alam U et al (2022) Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial. The Lancet, 400(10353), 680-690. View this article in WRRO
• Mountain G, Wright J, Cooper CL, Lee E, Sprange K, Beresford-Dent J, Young T, Walters S, Berry K, Dening T , Loban A et al (2022) An intervention to promote self-management, independence and self-efficacy in people with early-stage dementia : the Journeying through Dementia RCT. Health Technology Assessment, 26(24), 1-151. View this article in WRRO
• Mountain GA, Cooper CL, Wright J, Walters SJ, Lee E, Craig C, Berry K, Sprange K, Young T, Moniz-Cook E , Dening T et al (2022) The Journeying through Dementia psychosocial intervention versus usual care study: a single-blind, parallel group, phase 3 trial. The Lancet Healthy Longevity, 3(4), e276-e285. View this article in WRRO
• Shanahan TAG, Fuller GW, Sheldon T, Turton E, Quilty FMA & Marincowitz C (2021) External validation of the Dutch prediction model for prehospital triage of trauma patients in South West region of England, United Kingdom. Injury, 52(5), 1108-1116. View this article in WRRO
• Burton C, Mooney C, Sutton L, White D, Dawson J, Fryer K, Greco M, Horspool M, Neilson A, Rowlands G , Sanders T et al () Multiple Symptoms Study 3 – An extended-role general practitioner clinic for patients with persistent physical symptoms: a Randomised Controlled Trial. Health and Social Care Delivery Research, 1-24.